Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

0.6915

-0.0335 (-4.62%)

Sep 1, 2026, 4:00 PM EDT - Market closed

Estrella Immunopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	0.15	1.38	0.92	4.17	2.48	4.09
Cash & Short-Term Investments	0.15	1.38	0.92	4.17	2.48	4.09
Cash Growth	-88.86%	50.97%	-77.99%	68.02%	-39.36%	-
Receivables	-	-	-	-	0.27	-
Prepaid Expenses	1.68	0.29	0.72	0.29	-	0.83
Total Current Assets	1.82	1.68	1.64	4.45	2.75	4.92
Long-Term Deferred Charges	-	-	-	-	0.28	-
Other Long-Term Assets	-	1.5	1.5	-	-	-
Total Assets	1.82	3.18	3.14	4.45	3.03	4.92

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	0.01	0.55	0	-	-	-
Accrued Expenses	8.56	12.61	2.98	0.14	8.85	0.03
Current Portion of Leases	-	0.01	0	0	0.02	-
Current Income Taxes Payable	-	-	0	0.04	-	-
Other Current Liabilities	0.69	0.38	0.01	0	0.88	0.92
Total Current Liabilities	9.26	13.54	3	0.18	9.76	0.95
Other Long-Term Liabilities	-	-	-	-	0.01	0.01
Total Liabilities	9.26	13.54	3	0.18	9.77	0.96

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	34.75	27.22	24.64	24.12	0.45	0.03
Retained Earnings	-41.59	-36.99	-23.93	-19.5	-12.19	-1.07
Treasury Stock	-0.6	-0.6	-0.57	-0.35	-	-
Total Common Equity	-7.43	-10.37	0.14	4.27	-11.74	-1.04
Shareholders' Equity	-7.43	-10.37	0.14	4.27	-6.74	3.96
Total Liabilities & Equity	1.82	3.18	3.14	4.45	3.03	4.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	-	0.01	0	0	0.02	-
Net Cash (Debt)	0.15	1.38	0.91	4.16	2.46	4.09
Net Cash Growth	-88.83%	50.98%	-78.06%	69.36%	-39.90%	-
Net Cash Per Share	0.00	0.04	0.03	0.15	8.04	-
Filing Date Shares Outstanding	43.5	42.67	36.17	36.19	35.2	0.18
Total Common Shares Outstanding	43.03	37.97	36.19	36.29	4.06	0.18
Working Capital	-7.43	-11.87	-1.36	4.27	-7.01	3.97
Book Value Per Share	-0.17	-0.27	0.00	0.12	-2.89	-5.91
Tangible Book Value	-7.43	-10.37	0.14	4.27	-11.74	-1.04
Tangible Book Value Per Share	-0.17	-0.27	0.00	0.12	-2.89	-5.91

SEC Filings: 10-K · 10-Q